Immedica (private company)

See something wrong or missing? Let us know
Offices:Stockholm
Business model:B2B

Immedica was formed through the combination of an existing platform, recruitment of new management and key employees. Immedica will be built on the initial acquisition of Medical Need Europe – a rapidly growing, Northern Europe focused, launch- and commercial distribution partner for rare disease therapies and orphan drugs.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Immedica

Name Criteria
Iceland 3Z Pharmaceuticals
37%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
France ABC Transfer
37%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Spain Ability Pharma
37%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
France AbolerIS Pharma
37%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Denmark AFYX Therapeutics
37%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Germany Aignostics
37%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
France Algo Therapeutix
37%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Spain Amadix
37%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden Asarina Pharma
37%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden Athera
37%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Top